Schiff Nutrition Pays $5M In Dietary Supplement Labeling Row

Law360, Chicago (March 26, 2014, 10:01 PM EDT) -- Schiff Nutrition International Inc. has agreed to pay at least $5 million to settle a proposed class action accusing the company of falsely marketing its flagship dietary supplement as an arthritis treatment, according to a Tuesday filing in California federal court.

In a motion seeking preliminary approval of the deal, plaintiffs Luis Lerma and Nick Pearson said Schiff would refund at least $2 million to customers who purchased the supplement — a glucosamine and chondroitin concoction called Move Free Advanced — and cover $3 million of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.